RenovoRx, Inc.
RNXT
$1.34
-$0.01-0.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.88% | 9.68% | -13.00% | 2.90% | -36.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.56% | 50.53% | -5.20% | -10.10% | -24.07% |
| Operating Income | -25.61% | -48.11% | 5.20% | 10.10% | 24.07% |
| Income Before Tax | -124.91% | 10.81% | -73.89% | -2.66% | 66.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -124.91% | 10.81% | -73.89% | -2.66% | 66.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -124.91% | 10.81% | -73.89% | -2.66% | 66.96% |
| EBIT | -25.61% | -48.11% | 5.20% | 10.10% | 24.07% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -7.08% | 62.00% | 25.43% | 54.53% | 79.91% |
| Normalized Basic EPS | -7.11% | 62.02% | 25.51% | 54.51% | 79.90% |
| EPS Diluted | -7.08% | 62.00% | 25.43% | 54.53% | 79.91% |
| Normalized Diluted EPS | -7.11% | 62.02% | 25.51% | 54.51% | 79.90% |
| Average Basic Shares Outstanding | 110.04% | 134.70% | 133.24% | 125.70% | 64.44% |
| Average Diluted Shares Outstanding | 110.04% | 134.70% | 133.24% | 125.70% | 64.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |